Evidence map›Paper›PMID 36590458›Full record

ArticleEuropean journal of organic chemistry2022

H-Bonded Counterion-Directed Catalysis: Enantioselective Gold(I)-Catalyzed Addition to 2-Alkynyl Enones as a Case Study.

Àlex Martí, Marc Montesinos-Magraner, Antonio M Echavarren, Allegra Franchino

Open access · bronzeAbstract read
In one paragraph

Article in European journal of organic chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Àlex MartíInstitute of Chemical Research of Catalonia (ICIQ) Barcelona Institute of Science and Technology (BIST) Av. Països Catalans 16 43007 Tarragona Spain.ORCID 0000-0001-7455-598X
Marc Montesinos-MagranerInstitute of Chemical Research of Catalonia (ICIQ) Barcelona Institute of Science and Technology (BIST) Av. Països Catalans 16 43007 Tarragona Spain.ORCID 0000-0003-1713-6257
Antonio M EchavarrenInstitute of Chemical Research of Catalonia (ICIQ) Barcelona Institute of Science and Technology (BIST) Av. Països Catalans 16 43007 Tarragona Spain.ORCID 0000-0001-6808-3007
Allegra FranchinoInstitute of Chemical Research of Catalonia (ICIQ) Barcelona Institute of Science and Technology (BIST) Av. Països Catalans 16 43007 Tarragona Spain.ORCID 0000-0001-6955-5651
Institut Català d'Investigació Química · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

H-bonded counterion-directed catalysis (HCDC) is a strategy wherein a chiral anion that is hydrogen-bonded to the achiral ligand of a metal complex is responsible for enantioinduction. In this article we present the application of H-bonded counterion-directed catalysis to the Au(I)-catalyzed enantioselective tandem cycloisomerization-addition reaction of 2-alkynyl enones. Following the addition of C-, N- or O-centered nucleophiles, bicyclic furans were obtained in moderate to excellent yield and enantioselectivity (28 examples, 59-96 % yield, 62 : 38 to 95 : 5 er). The optimal catalytic system, comprising a phosphinosquaramide Au(I) chloride complex and a BINOL-derived phosphoramidate Ag(I) salt, was selected in a combinatorial fashion from a larger library with the help of high-throughput screening. An enantioselectivity switch of ca. 120 Δee% was observed upon addition of the achiral Au(I) component to the Ag(I) salt.

Indexed as

Asymmetric catalysisChiral counterionGoldHydrogen bondingYnenones

Identifiers

PMID36590458
PMCPMC9796400
OpenAlexW4283319849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.